Last 48 quarters of trend data · Consumer Cyclical · Specialty Retail
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -41.72 | — | — | 832.69 | 119.34 | 75.49 | 495.83 | 117.55 | 102.13 | 46.96 | 88.33 | — | 54.89 |
| — | — | — | +608.4% | +16.8% | +60.8% | +461.3% | — | +86.1% | -9.6% | -60.5% | — | — | |
| P/S Ratio | 0.93 | 0.91 | 1.36 | 1.27 | 1.35 | 1.22 | 1.60 | 1.95 | 1.75 | 1.54 | 1.43 | 1.50 | 1.19 |
| — | -25.5% | -15.2% | -34.8% | -22.9% | -20.3% | +11.8% | +29.4% | +47.5% | +96.1% | +59.8% | +31.0% | -31.0% | |
| P/B Ratio | 1.57 | 1.52 | 1.97 | 1.73 | 1.88 | 1.61 | 1.94 | 2.19 | 1.95 | 1.61 | 1.40 | 1.39 | 1.17 |
| — | -6.0% | +1.5% | -21.2% | -3.6% | -0.0% | +38.2% | +57.3% | +66.2% | +106.6% | +73.6% | +23.7% | -16.1% | |
| P/FCF | — | 49.94 | 183.59 | — | 31.06 | 195.09 | — | — | 35.72 | — | — | — | — |
| — | -74.4% | — | — | -13.1% | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Natural Health Trends Corp.'s operating margin was -6.5% in Q4 2025, down 1.3 pp QoQ and down 2.6 pp YoY. This marks the 4th consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of -4.6% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.5% | 72.9% | 73.7% | 73.9% | 73.6% | 74.2% | 74.1% | 74.2% | 73.4% | 74.5% | 74.7% | 74.6% | 74.4% |
| — | -1.7% | -0.6% | -0.4% | +0.3% | -0.4% | -0.7% | -0.5% | -1.4% | +0.8% | +1.5% | +0.0% | -0.5% | |
| Operating Margin | -4.5% | -6.5% | -5.2% | -3.4% | -3.2% | -3.9% | -2.6% | -2.3% | -3.3% | -2.2% | -2.8% | -7.1% | -3.3% |
| — | -67.8% | -103.1% | -49.4% | +3.6% | -75.4% | +6.5% | +67.9% | -0.3% | -743.8% | -122.3% | -539.2% | -0.1% | |
| Net Margin | -2.2% | -6.0% | -4.5% | 0.2% | 1.1% | 1.6% | 0.3% | 1.7% | 1.7% | 3.3% | 1.6% | -2.1% | 2.2% |
| — | -471.7% | -1489.1% | -90.7% | -33.8% | -50.4% | -79.8% | +179.3% | -20.8% | +117.8% | +303.9% | -252.1% | +338.3% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -3.1% | -2.4% | -1.6% | 0.1% | 0.4% | 0.5% | 0.1% | 0.5% | 0.5% | 0.8% | 0.4% | -0.5% | 0.5% |
| — | -559.4% | -1724.0% | -88.9% | -17.6% | -38.8% | -75.1% | +196.4% | -11.3% | +128.9% | +339.1% | -242.6% | +390.0% | |
| ROA | -1.9% | -1.5% | -1.0% | 0.0% | 0.2% | 0.3% | 0.1% | 0.3% | 0.3% | 0.5% | 0.2% | -0.3% | 0.3% |
| — | -570.6% | -1788.5% | -88.6% | -18.3% | -39.0% | -75.1% | +194.8% | -12.8% | +126.2% | +330.5% | -239.8% | +387.4% | |
| ROIC | -6.5% | -2.9% | -2.1% | -1.5% | -1.5% | -1.7% | -1.0% | -0.9% | -9.4% | — | — | — | — |
| — | -72.7% | -109.4% | -81.4% | +83.6% | — | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Debt/Equity has risen for 3 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.13 | 0.09 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.09 | 0.08 | 0.09 | 0.08 | 0.08 |
| — | +6.3% | -0.2% | -9.0% | -6.9% | -3.5% | -3.4% | +4.7% | +3.6% | +1.3% | +2.2% | +70.2% | +66.4% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.50 | 2.50 | 2.57 | 2.73 | 2.35 | 2.45 | 2.55 | 2.57 | 3.01 | 3.21 | 3.22 | 3.25 | 3.75 |
| — | +1.9% | +0.7% | +6.3% | -21.8% | -23.7% | -20.9% | -20.8% | -19.7% | -15.3% | -17.4% | -12.3% | -6.5% | |
| Quick Ratio | 2.35 | 2.35 | 2.42 | 2.55 | 2.22 | 2.29 | 2.38 | 2.38 | 2.77 | 3.00 | 2.99 | 3.03 | 3.50 |
| — | +2.4% | +1.9% | +7.1% | -20.0% | -23.5% | -20.5% | -21.4% | -20.7% | -16.1% | -18.3% | -12.8% | -7.6% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonNatural Health Trends Corp.'s current P/E is -41.7x. The average P/E over the last 2 quarters is 476.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Natural Health Trends Corp.'s current operating margin is -4.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Natural Health Trends Corp.'s business trajectory between earnings reports.